fracasso, giulio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.285
AS - Asia 971
EU - Europa 708
SA - Sud America 277
AF - Africa 241
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 10
Totale 4.521
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.165
SG - Singapore 314
IT - Italia 206
BR - Brasile 200
CN - Cina 198
HK - Hong Kong 159
DE - Germania 68
VN - Vietnam 55
NL - Olanda 52
FI - Finlandia 47
PL - Polonia 40
CI - Costa d'Avorio 31
GB - Regno Unito 29
RU - Federazione Russa 29
SE - Svezia 27
FR - Francia 24
MX - Messico 24
AR - Argentina 21
UA - Ucraina 21
IN - India 17
ZA - Sudafrica 15
KR - Corea 13
IQ - Iraq 12
TR - Turchia 12
UZ - Uzbekistan 12
BD - Bangladesh 11
LV - Lettonia 11
NP - Nepal 11
KZ - Kazakistan 10
SI - Slovenia 10
AT - Austria 9
CA - Canada 9
CV - Capo Verde 9
ES - Italia 9
JP - Giappone 9
LC - Santa Lucia 9
NO - Norvegia 9
PH - Filippine 9
PS - Palestinian Territory 9
PY - Paraguay 9
UY - Uruguay 9
AF - Afghanistan, Repubblica islamica di 8
BZ - Belize 8
CH - Svizzera 8
CO - Colombia 8
EC - Ecuador 8
EG - Egitto 8
LA - Repubblica Popolare Democratica del Laos 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
BE - Belgio 7
BG - Bulgaria 7
DJ - Gibuti 7
GR - Grecia 7
ID - Indonesia 7
IL - Israele 7
LY - Libia 7
MA - Marocco 7
MU - Mauritius 7
NZ - Nuova Zelanda 7
PA - Panama 7
PT - Portogallo 7
SO - Somalia 7
TW - Taiwan 7
UG - Uganda 7
CG - Congo 6
CL - Cile 6
CZ - Repubblica Ceca 6
EE - Estonia 6
GM - Gambi 6
GN - Guinea 6
IE - Irlanda 6
LB - Libano 6
ME - Montenegro 6
MR - Mauritania 6
NG - Nigeria 6
PR - Porto Rico 6
RO - Romania 6
SK - Slovacchia (Repubblica Slovacca) 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
WS - Samoa 6
YT - Mayotte 6
ZM - Zambia 6
AM - Armenia 5
AO - Angola 5
AU - Australia 5
BO - Bolivia 5
BY - Bielorussia 5
CM - Camerun 5
CW - ???statistics.table.value.countryCode.CW??? 5
DZ - Algeria 5
GA - Gabon 5
GT - Guatemala 5
HN - Honduras 5
KE - Kenya 5
KG - Kirghizistan 5
KH - Cambogia 5
MG - Madagascar 5
Totale 4.315
Salva come PNG Salva come JPEG
Città #
Fairfield 314
Ashburn 222
Woodbridge 215
Singapore 200
Ann Arbor 156
Hong Kong 156
Chandler 138
Houston 138
Seattle 106
Cambridge 95
Santa Clara 93
Wilmington 89
Beijing 70
Jacksonville 48
Padova 48
Boardman 43
San Diego 34
Bytom 32
Abidjan 30
Munich 28
Princeton 28
Medford 23
Milan 22
Helsinki 17
Los Angeles 16
Ho Chi Minh City 15
Nanjing 15
Buffalo 14
Des Moines 14
Nuremberg 13
Roxbury 13
São Paulo 13
Verona 13
Hefei 12
Turku 12
Dong Ket 11
Tashkent 11
Johannesburg 10
New York 10
Castries 9
Hanoi 9
Redondo Beach 9
Rome 9
Montevideo 8
Riga 8
Rio de Janeiro 8
Villafranca Padovana 8
Baku 7
Curitiba 7
Djibouti 7
Mexico City 7
Praia 7
Apia 6
Cairo 6
Conakry 6
Kampala 6
Ljubljana 6
Lusaka 6
Nouakchott 6
Panama City 6
Venice 6
Vientiane 6
Antananarivo 5
Auckland 5
Baghdad 5
Bangkok 5
Belize City 5
Dakar 5
Dublin 5
Istanbul 5
Kilburn 5
Libreville 5
Luanda 5
Medellín 5
Nairobi 5
Noumea 5
Oslo 5
Phnom Penh 5
Salvador 5
Sanaa 5
Seoul 5
Shenyang 5
Tokyo 5
Tripoli 5
Yerevan 5
Almaty 4
Amman 4
Bamako 4
Bishkek 4
Boston 4
Brasília 4
Brazzaville 4
Brooklyn 4
Chicago 4
Cuauhtémoc 4
Dhaka 4
Douala 4
Erbil 4
Fort-de-France 4
Genoa 4
Totale 2.875
Salva come PNG Salva come JPEG
Nome #
Safe core-satellite magneto-plasmonic nanostructures for efficient targeting and photothermal treatment of tumor cells 207
Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate Cancer 175
Plasmonic Nanostructures for SERRS Multiplexed Identification of Tumor-Associated Antigens 166
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 163
Laser generated gold nanocorals with broadband plasmon absorption for photothermal applications 160
Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems 159
Magneto-Plasmonic Au-Fe Alloy Nanoparticles Designed for Multimodal SERS-MRI-CT Imaging 159
A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer. 158
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 146
Nanoaggregates of iron poly-oxo-clusters obtained by laser ablation in aqueous solution of phosphonates 146
SERS labels for quantitative assays: application to the quantification of gold nanoparticles uptaken by macrophage cells 140
SERRS multiplexing with multivalent nanostructures for the identification and enumeration of epithelial and mesenchymal cells 136
New 99mTc-radioimmunoconjugates for pancreatic carcinoma detection 133
Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen 130
Polymer-coated silver-iron nanoparticles as efficient and biodegradable MRI contrast agents 128
PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models. 116
Top-down synthesis of multifunctional iron oxide nanoparticles for macrophage labelling and manipulation 116
Parallel optical read-out of micromechanical pillars applied to prostate specific membrane antigen detection 108
Targeted killing of prostate cancer cells using antibody–drug conjugated carbon nanohorns 108
Efficient AuFeOxNanoclusters of Laser-Ablated Nanoparticles in Water for Cells Guiding and Surface-Enhanced Resonance Raman Scattering Imaging 103
Preparation and quantitative study of gold nanoparticles forSERS biolabelling 98
Preclinical dosimetric studies of 177Lu-scFvD2B and comparison with 177Lu-PSMA-617 and 177Lu-iPSMA endoradiotherapeutic agents 98
Conjugation and characterization of a new prostate cancer theranostic radiopharmaceutical 93
Development and Characterization of 99mTc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer 91
SERS active gold nanostructures for selective and ultrabright biolabelling: synthesis and quantitative study 91
PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB "Super-Stimulation" 90
Synthesis a new radiopharmaceutical for prostate cancer SPECT imaging 89
Comparison of preclinical dosimetric studies of 177Lu-scFvD2B, 177Lu-PSMA-617 and 177Lu-iPSMA. 86
G Protein-Coupled Receptors and the Rise of Type 2 Diabetes in Children 86
Point mutations of the mitochondrial chaperone TRAP1 affect its functions and pro-neoplastic activity 82
Preclinical dosimetric studies of 177Lu-scFvD2B, 177Lu-PSMA-617 and 177Lu-iPSMA 80
Magnetic-plasmonic nanoalloys: a new class of multimodal theranostic tool 77
High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors 62
Gangliosides act as onconeural antigens in paraneoplastic neuropathies 61
Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers 60
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 59
Mitoxantrone-loaded nanoferritin slows tumor growth and improves the overall survival rate in a subcutaneous pancreatic cancer mouse model 53
Human blood biocompatibility and immunogenicity of scFvD2B PEGylated gold nanoparticles 51
D2B antibody and its scFvD2B fragment in nanomedicine: Promising tools in the theranostics of prostate cancer 50
Design and evaluation of 223Ra-labeled and Anti-PSMA targeted NaA nanozeolites for prostate cancer therapy—part ii. Toxicity, pharmacokinetics and biodistribution 48
Simple and rapid non-enzymatic procedure allows the isolation of structurally preserved connective tissue micro-fragments enriched with svf 46
Engineered human nanoferritin bearing the drug genz-644282 for cancer therapy 44
Design and evaluation of 223Ra-labeled and anti-PSMA targeted NaA nanozeolites for prostate cancer therapy-Part I 43
D2B-Functionalized Gold Nanoparticles: Promising Vehicles for Targeted Drug Delivery to Prostate Cancer 42
Upgrading gold to green nanoparticles: applications in prostate cancer 38
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 22
Totale 4.597
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.047
article - articoli 13.023
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.070
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021323 0 0 36 57 8 9 12 26 40 61 33 41
2021/2022377 44 36 58 21 21 10 26 38 21 4 33 65
2022/2023264 52 31 6 30 46 23 8 16 21 12 17 2
2023/2024294 11 21 52 35 27 46 42 9 10 9 16 16
2024/20251.292 11 111 43 40 142 34 84 135 153 62 219 258
2025/20261.177 237 362 578 0 0 0 0 0 0 0 0 0
Totale 4.597